Inscobee Inc. 13D and 13G filings for Apimeds Pharmaceuticals US, Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 09:11 am Unchanged | 2026-05-07 | 13D | APIMEDS PHARMACEUTICALS US INC APUS | Inscobee Inc. | 4,316,618 34.300% | 0 (Unchanged) | Filing |
| 2026-03-30 08:20 am Purchase | 2026-03-25 | 13D | APIMEDS PHARMACEUTICALS US INC APUS | Inscobee Inc. | 4,316,618 34.300% | 3,884,956 (+900.00%) | Filing |
| 2026-03-20 6:21 pm Unchanged | 2026-03-20 | 13D | APIMEDS PHARMACEUTICALS US INC APUS | Inscobee Inc. | 431,662 34.300% | 0 (Unchanged) | Filing |
| 2026-01-26 06:03 am Sale | 2025-12-01 | 13D | APIMEDS PHARMACEUTICALS US INC APUS | Inscobee Inc. | 431,662 34.300% | -7,109 (-1.62%) | Filing |
| 2025-05-19 9:29 pm Purchase | 2025-05-12 | 13D | APIMEDS PHARMACEUTICALS US INC APUS | Inscobee Inc. | 438,771 37.900% | 438,771 (New Position) | Filing |